๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Assessment Of Guided Bone Regeneration Using Xenograft Mixed With Allogenic Bone Graft Versus Xenograft Mixed With Autogenous Graft For Augmentation Of Maxillary Alveolar Ridges

RecruitingNAAges 20 Years - 50 YearsAllCairo University
NCT07367464 on ClinicalTrials.gov โ†—
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This study aims to evaluate the effect of Allogenic bone graft mixed with Xenograft in ratio 1:1, on the radiographic and histomorphometric assessment versus Autologous bone graft mixed with Xenograft in ratio 1:1 in maxillary deficient ridgesุŒ In guided bone regeneration of deficient edentulous maxillary ridges, will the application of Xenograft mixed with Allograft (1:1) be as effective as Xenograft mixed with Autogenous graft (1:1) in terms of dimensional ridge changes and Quality of newly formed bone? Evaluation of the patient's general condition of the oral cavity, to make sure it complies with the criteria required to be enrolled in the study in terms of oral hygiene and pathological conditions. A full thickness flap will be elevated with two releasing incisions, decortication of the buccal aspect of the ridge, placing of grafting material which will be covered by collagen perica

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Age: 20-50 years. * Totally or partially edentulous maxillary ridges. * Patients with insufficient bone for an implant placement. * Residual alveolar width ranging from 2 to 4 mm. * Minimum of 10 mm vertical dimension to nasal floor or sinus floor. * Patients with healthy systemic condition (Medically free). * Adequate inter-arch space for placement of the implant prosthetic part. Exclusion Criteria: * Pathological lesions in the defect site. * Systemic diseases that would interfere with bone metabolism. Uncontrolled diabetic patients. * Ongoing treatment or a history of recent chemotherapy or radiotherapy. * Patient with medical condition that contraindicates surgical procedures. * Patients on medication that may interfere with healing (Corticosteroids, Bisphosphonate, Chemo/radio therapy). * Patients with vertical bone deficiency. * Patients with habits that may jeopardize the implant longevity and affect the results of the study such as alcoholism or para-functional habits.
๐Ÿ’Š

What it tests

  • Allogenic bone graft mixed with Xenograft in ratio 1:1
  • Autologous bone graft mixed with Xenograft in ratio 1:1
๐Ÿ“

Where

1 site
Faculty of Dentistry Cairo University
Cairo, Egypt
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy